These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10779767)

  • 1. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.
    Widera G; Austin M; Rabussay D; Goldbeck C; Barnett SW; Chen M; Leung L; Otten GR; Thudium K; Selby MJ; Ulmer JB
    J Immunol; 2000 May; 164(9):4635-40. PubMed ID: 10779767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.
    Dupuis M; Denis-Mize K; Woo C; Goldbeck C; Selby MJ; Chen M; Otten GR; Ulmer JB; Donnelly JJ; Ott G; McDonald DM
    J Immunol; 2000 Sep; 165(5):2850-8. PubMed ID: 10946318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated immune response to DNA vaccines.
    Zhang L; Widera G; Bleecher S; Zaharoff DA; Mossop B; Rabussay D
    DNA Cell Biol; 2003 Dec; 22(12):815-22. PubMed ID: 14683592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
    Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN
    Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.
    Hirao LA; Wu L; Khan AS; Hokey DA; Yan J; Dai A; Betts MR; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jun; 26(25):3112-20. PubMed ID: 18430495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine.
    Liu J; Wyatt LS; Amara RR; Moss B; Robinson HL
    Vaccine; 2006 Apr; 24(16):3332-9. PubMed ID: 16472543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.
    Mann JF; McKay PF; Fiserova A; Klein K; Cope A; Rogers P; Swales J; Seaman MS; Combadiere B; Shattock RJ
    J Virol; 2014 Jun; 88(12):6959-69. PubMed ID: 24719412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
    zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
    J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids.
    Chen H; Wen B; Deng Y; Wang W; Yin X; Guan J; Ruan L; Tan W
    Clin Vaccine Immunol; 2011 Nov; 18(11):1789-95. PubMed ID: 21900535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
    Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB
    Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.
    Luckay A; Sidhu MK; Kjeken R; Megati S; Chong SY; Roopchand V; Garcia-Hand D; Abdullah R; Braun R; Montefiori DC; Rosati M; Felber BK; Pavlakis GN; Mathiesen I; Israel ZR; Eldridge JH; Egan MA
    J Virol; 2007 May; 81(10):5257-69. PubMed ID: 17329330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W; Yang ZY; Nabel GJ
    J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.
    Otten GR; Schaefer M; Doe B; Liu H; Megede JZ; Donnelly J; Rabussay D; Barnett S; Ulmer JB
    Vaccine; 2006 May; 24(21):4503-9. PubMed ID: 16181711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on Cellular Immune Responses of DNA Vaccine, rAd5 and rMVA Expressing SIV Gag/Env Gene Combined Immunization in Mice].
    He X; Chen D; Wang W; Xu K; Zeng Y; Feng X
    Bing Du Xue Bao; 2016 Mar; 32(2):170-8. PubMed ID: 27396160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
    Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
    DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus.
    Fomsgaard A; Nielsen HV; Nielsen C; Johansson K; Machuca R; Bruun L; Hansen J; Buus S
    APMIS; 1998 Jun; 106(6):636-46. PubMed ID: 9725796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.